NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE63124 Query DataSets for GSE63124
Status Public on Oct 24, 2016
Title Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq]
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary During pancreatic cancer progression, heterogeneous subclonal populations evolve in the primary tumor that possess differing capacities to metastasize and cause patient death. However, the genetics of metastasis reflects that of the primary tumor, and PDAC driver mutations arise early. This raises the possibility than an epigenetic process could be operative late. Using an exceptional resource of paired patient samples, we found that different metastatic subclones from the same patient possessed remarkably divergent malignant properties and global epigenetic programs. Global reprogramming was targeted to thousands of large chromatin domains across the genome that collectively specified malignant divergence. This was maintained by a metabolic shift within the pentose phosphate pathway, independent of KRAS driver mutations. Analysis of paired primary and metastatic tumors from multiple patients uncovered substantial epigenetic heterogeneity in primary tumors, which resolved into a terminally reprogrammed state in metastatic lesions. This supports a model whereby driver mutations accumulate early to initiate pancreatic tumorigenesis, followed by a period of subclonal evolution that generates sufficient intra-tumor heterogeneity for selection of epigenetic programs that may increase fitness during malignant progression and metastatic spread.
 
Overall design To map the epigenomic landscape of pancreatic cancer progression as it evolves within patients. RNA-Seq of 2 patients (A13 and A38). Patient A38 included local peritoneal metastasis and 2 distant metastsis (liver and lung mets), and 6AN treated and DMSO control samples. Patient A13 included 2 primary tumors and 1 distant lung metastasis. Each sample has been done with replicates.
 
Contributor(s) McDonald OG, Li X, Iacobuzio-Donahue C, Feinberg AP
Citation(s) 28092686
Submission date Nov 09, 2014
Last update date May 15, 2019
Contact name Xin Li
E-mail(s) lixin4306ren@gmail.com
Organization name Sun Yat-sen University
Department School of Medicine
Street address 132 Daxuecheng Outer Ring E Rd
City Guangzhou
State/province Guangdong
ZIP/Postal code 510006
Country China
 
Platforms (1)
GPL11154 Illumina HiSeq 2000 (Homo sapiens)
Samples (20)
GSM1541792 38-Per_rep1 [RNA-Seq]
GSM1541793 38-Per_rep2 [RNA-Seq]
GSM1541794 38-Per_SFM_rep1 [RNA-Seq]
This SubSeries is part of SuperSeries:
GSE63126 Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression
Relations
BioProject PRJNA266736
SRA SRP049650

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE63124_all_gene_raw_readcounts.txt.gz 491.0 Kb (ftp)(http) TXT
GSE63124_all_gene_raw_readcounts2.txt.gz 660.0 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Processed data are available on Series record
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap